Researchers report the first structural confirmation that endogenous -- or self-made -- molecules can set off innate immunity in mammals via a pair of immune cell proteins called the TLR4-MD-2 receptor complex. The work has wide-ranging implications for finding ways to treat and possibly prevent autoimmune diseases such as multiple sclerosis and antiphospholipid syndrome.
from Latest Science News -- ScienceDaily https://ift.tt/36WGehI
via IFTTT
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment